Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Novanta
NOVT
Market cap
$4.7B
Overview
Fund Trends
Analyst Outlook
Journalist POV
131.34
USD
-0.13
0.1%
At close
Updated
Jan 14, 4:00 PM EST
Pre-market
After hours
131.34
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-0.1%
5 days
7.21%
1 month
9.99%
3 months
24.67%
6 months
3.73%
Year to date
18.18%
1 year
-11.39%
5 years
0.74%
10 years
777.35%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
71.4%
Negative
Positive
Neutral
Negative
Neutral
Seeking Alpha
9 days ago
Goldman Sachs Small/Mid Cap Growth Fund Q3 2025 Portfolio Update
The Goldman Sachs Small/Mid Cap Growth Fund-Institutional Shares underperformed its benchmark, the Russell 2500 Growth Index (net), during the quarter. We initiated a position in Planet Fitness, Inc. (1.3%), a franchiser and operator of fitness centers, during the quarter. We exited our position in American fast casual restaurant chain, Shake Shack Inc. (0.0%), during the quarter.
Neutral
Business Wire
27 days ago
Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Chuck Ravetto, Chief Operating Officer, will be participating at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced in.
Neutral
Business Wire
1 month ago
Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solutions.
Negative
Seeking Alpha
2 months ago
5 Tech And Consumer Stocks At Risk Of Steep Declines
As the market grows increasingly top-heavy, the risks for fundamentally weaker and average-strength companies are increasing. The number of stocks losing momentum over the past year has mounted as mega-cap tech and AI-driven names rocketed higher. While there are Strong Buys to be had outside of the mega-cap tech stocks, the downside risk is mounting for the weaker ones.
Neutral
Business Wire
2 months ago
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has priced its previously announced public offering of 11 million of its 6.50% tangible equity units at $50.00 per unit (equal to the stated amount per unit). The transaction is a public offering made by means of a prospectus supplement under Novanta's effective shelf registration statement. Novanta's.
Neutral
Business Wire
2 months ago
Novanta Inc. Announces Offering of Tangible Equity Units
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has commenced a public offering of 11 million tangible equity units, with an aggregate stated amount of $550.0 million. Each tangible equity unit will have a stated amount of $50.00 and be comprised of a prepaid stock purchase contract and a senior amortizing note due 2028, each issued by Novanta. The.
Neutral
Seeking Alpha
2 months ago
Novanta Inc. (NOVT) Q3 2025 Earnings Call Transcript
Novanta Inc. ( NOVT ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Ray Nash - Corporate Finance Leader & IR Matthijs Glastra - CEO & Chairman of the Board Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities, Inc. Robert Mason - Robert W. Baird & Co. Incorporated, Research Division Brian Drab - William Blair & Company L.L.C.
Positive
Zacks Investment Research
2 months ago
Novanta (NOVT) Surpasses Q3 Earnings and Revenue Estimates
Novanta (NOVT) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.85 per share a year ago.
Neutral
Business Wire
2 months ago
Novanta Announces Financial Results for the Third Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) September 26, September 27, 2025 2024 GAAP Revenue $ 247.8 $ 244.4 Operating Income $ 21.8 $ 32.6 Net Income $ 10.7 $ 19.2 Diluted EPS $ 0.30 $ 0.53.
Neutral
Business Wire
2 months ago
Novanta to Present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, in London. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close